Clinical Trials starting soon
At CSAR, our mission is to provide evidence-based clinical trials for the health of our community. We strive to contribute to the advancement of medical research and the understanding of human health. Our team of scientists and researchers are committed to delivering the highest quality of care with the utmost integrity.
CSAR is dedicated to providing our patients with the most innovative and reliable medical treatments. Our clinical trials are evidence-based and designed to provide patients with the best possible outcomes. We invite you to join us in our mission to improve the health of our community.
06
The SANE-03 Trial: Treatment of neonatal encephalopathy with oral sidenafil suspension to repair brain injury secondary to birth asphyxia: A randomized, double-blind, placebo-controlled clinical trial to evaluate safety and efficacy (Phase II study)
04
The OXY-PREEM Trial: Does the use of 60% vs 30% oxygen reduce respiratory support in 32-35 week preterm infants?
03
The SURV1VE-2 - Trial: Sustained Inflation during Chest Compression (CC+SI) vs 3:1 Compression:Ventilation ration during neonatal Resuscitation: Multicenter Cluster Trial
02
The OPTISTART - Trial: Optimization of Saturation Targets and Resuscitation (OptiSTART): Multicenter Randomized Controlled Trial
01
The SURFSUP - Trial: SURFactant Administraion by SUPraglottic Airway